Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
Pain location reveals anatomical origin: groin and thigh pain indicates hip joint disease; lateral pain reflects gluteal tendon pathology; buttock pain typically originates from the lumbar spine or sacroiliac joint. Each origin requires different treatment; misidentifying the source delays effective recovery.
Hip cartilage is avascular — lacking blood vessels to mount the inflammatory cascade that heals most other tissues — so damage produces fibrocartilage, scar tissue that deteriorates under load within two to three years.
Landmark-guided hip injections achieve accurate placement in only 72% of cases; ChondroFiller, a collagen hydrogel that hardens irreversibly within three to five minutes, makes ultrasound guidance a biological necessity rather than a procedural refinement.
AMIC combines microfracture with a collagen scaffold to stabilise and guide cartilage repair: a systematic review of 209 hips recorded zero conversions to hip replacement in AMIC-treated patients versus up to 32.6% in microfracture-alone controls.
Corticosteroid and hyaluronic acid injections show no significant benefit for hip osteoarthritis in recent meta-analyses; Liquid Cartilage, a collagen scaffold, recruits the body's own cells to regenerate cartilage tissue instead.
For most people with hip osteoarthritis, surgery is not needed within 10–20 years; but femoroacetabular impingement (FAI), which causes roughly 50% of cases, shows radiographic worsening in 48% of untreated patients over 12 years, dropping to 28% with early intervention.
In more than 19,000 ChondroFiller hip injections since 2013, zero serious adverse events have been recorded; the most frequent complaint, non-gelation at 0.01%, causes no patient harm.
ChondroFiller™, an injectable collagen scaffold, recruits the patient's own progenitor cells to repair focal hip cartilage defects; published data report approximately 30-point improvement in hip function and 3–8% reoperation rates.
The decision between hip cartilage repair and replacement turns on the structural state of the joint, not on age or pain level. Focal cartilage damage in an otherwise intact joint is repairable; bone-on-bone contact is not.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
